1. Home
  2. PACK vs MRVI Comparison

PACK vs MRVI Comparison

Compare PACK & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ranpak Holdings Corp

PACK

Ranpak Holdings Corp

HOLD

Current Price

$3.60

Market Cap

420.2M

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

SELL

Current Price

$7.06

Market Cap

1.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PACK
MRVI
Founded
1972
2014
Country
United States
United States
Employees
N/A
415
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
420.2M
1.1B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
PACK
MRVI
Price
$3.60
$7.06
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$7.08
★ $8.50
AVG Volume (30 Days)
537.2K
★ 2.2M
Earning Date
11-02-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 14.29
EPS
N/A
★ N/A
Revenue
★ $395,000,000.00
$185,743,000.00
Revenue This Year
$9.87
$14.01
Revenue Next Year
$9.00
$6.20
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 7.08
N/A
52 Week Low
$3.22
$2.55
52 Week High
$7.81
$9.42

Technical Indicators

Market Signals
Indicator
PACK
MRVI
Relative Strength Index (RSI) 35.87 47.36
Support Level $3.29 $6.41
Resistance Level $3.82 $7.60
Average True Range (ATR) 0.18 0.54
MACD 0.01 -0.02
Stochastic Oscillator 37.65 28.51

Price Performance

Historical Comparison
PACK
MRVI

About PACK Ranpak Holdings Corp

Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: